Table 1 Baseline demographics in AKI patients
Characteristic | All patients | High protein | Usual protein |
|---|---|---|---|
N | 312 | 163 | 149 |
Age (years) | (312) 60.7 ± 14.6 (20.0–95.0) | (163) 60.8 ± 13.6 (22.0–95.0) | (149) 60.6 ± 15.7 (20.0–93.0) |
Sex | |||
Male | 191 (61.2%) | 102 (62.6%) | 89 (59.7%) |
Female | 120 (38.5%) | 61 (37.4%) | 59 (39.6%) |
Admission status | |||
Medical | 278 (89.1%) | 144 (88.3%) | 134 (89.9%) |
Surgical elective | 11 (3.5%) | 5 (3.1%) | 6 (4.0%) |
Surgical emergency | 23 (7.4%) | 14 (8.6%) | 9 (6.0%) |
ICU admission status | |||
Baseline SOFA score | (312) 9.7 ± 3.7 (0.0–22.0) | (163) 9.7 ± 3.5 (0.0–18.0) | (149) 9.7 ± 3.9 (0.0–22.0) |
APACHE II score | (298) 23.7 ± 8.0 (6.0–55.0) | (155) 23.7 ± 7.6 (6.0–45.0) | (143) 23.7 ± 8.3 (6.0–55.0) |
NUTRIC score | (298) 5.4 ± 1.7 (0.0–9.0) | (155) 5.3 ± 1.6 (0.0–9.0) | (143) 5.4 ± 1.9 (1.0–9.0) |
Frailty | (284) 3.9 ± 1.6 (1.0–8.0) | (152) 3.9 ± 1.6 (1.0–8.0) | (132) 3.9 ± 1.7 (1.0–8.0) |
Frailty (clinical frailty scale ≥ 5) | 94 (30.1%) | 48 (29.4%) | 46 (30.9%) |
Patients received renal replacement therapies on randomization day | |||
Yes | 69 (22.1%) | 39 (23.9%) | 30 (20.1%) |
No | 243 (77.9%) | 124 (76.1%) | 119 (79.9%) |
Patients ever received KRT post randomization | |||
Yes | 107 (34.3%) | 60 (36.8%) | 47 (31.5%) |
No | 205 (65.7%) | 103 (63.2%) | 102 (68.5%) |
Patients ever versus never dialyzed | |||
Yes | 116 (37.2%) | 65 (39.9%) | 51 (34.2%) |
No | 196 (62.8%) | 98 (60.1%) | 98 (65.8%) |
Acute kidney injury* | |||
Stage 1 | 120 (38.5%) | 59 (36.2%) | 61 (40.9%) |
Stage 2 | 74 (23.7%) | 43 (26.4%) | 31 (20.8%) |
Stage 3 | 118 (37.8%) | 61 (37.4%) | 57 (38.3%) |
Chronic kidney disease | |||
Yes | 63 (20.2%) | 35 (21.5%) | 28 (18.8%) |
No | 249 (79.8%) | 128 (78.5%) | 121 (81.2%) |